Ti trovi qui: Home » Ricerca » Gruppi di Ricerca

Fisiopatologia, clinica e trattamento delle malattie cardiovascolari

Responsabile

Prof. Giuseppe Boriani (PO)

Obiettivi dell'attività di ricerca

Studiare le malattie cardiovascolari, con particolare attenzione alle aritmie, cardiopatia ischemica, insufficienza cardiaca, cardiopatie valvolari per quanto riguarda fisiopatologia, diagnosi e trattamenti sia farmacologici che non farmacologici.

 

Collaborazioni

  • Cardiology Div. Liverpool Univ. (UK)
  • Belgrade Univ.(Serbia) 
  • Karolinka University Stockholm (Svezia) 
  • Cardiology Dept. Universitè de Marseille (FR)
  • McMaster University, Hamilton, Ontario (Canada)

 

Pubblicazioni più significative sull’argomento

  • Boriani G, Padeletti L. Management of atrial fibrillation in bradyarrhythmias. Nat Rev Cardiol. 2015 Jun;12(6):337-49. doi: 10.1038/nrcardio.2015.30. Epub 2015 
  • Freedman B, Boriani G, Glotzer TV, Healey JS, Kirchhof P, Potpara TS. Management of atrial high-rate episodes detected by cardiac implanted electronic  devices. Nat Rev Cardiol. 2017 Dec;14(12):701-714. doi: 10.1038/nrcardio.2017.94.
  • Boriani G, Tukkie R, Manolis AS, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, de Sousa J, Botto GL, Mangoni L, Grammatico A, Padeletti L; MINERVA Investigators. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J. 2014 Sep 14;35(35):2352-62. doi: 10.1093/eurheartj/ehu165. 
  • Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M, Gasparini M, Lewalter T, Camm JA, Singer DE. Device-detected atrial fibrillation and risk for  stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014 Feb;35(8):508-16. doi: 10.1093/eurheartj/eht491. 
  • Boriani G, Maniadakis N, Auricchio A, Müller-Riemenschneider F, Fattore G, Leyva F, Mantovani L, Siebert M, Willich SN, Vardas P, Kirchhof P. Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. Eur Heart J. 2013 Jul;34(25):1869-74. doi: 10.1093/eurheartj/eht031. 
  • Boriani G, Gasparini M, Landolina M, Lunati M, Biffi M, Santini M, Padeletti L, Molon G, Botto G, De Santo T, Valsecchi S; InSync/InSync ICD Italian Registry  Investigators. Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. Eur Heart J. 2009 Sep;30(18):2275-83. doi:10.1093/eurheartj/ehp226. 
  • Rocchi G, Bertini M, Biffi M, Ziacchi M, Biagini E, Gallelli I, Martignani C,  Cervi E, Ferlito M, Rapezzi C, Branzi A, Boriani G. Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. Eur Heart J. 2009 Jan;30(1):89-97. doi:10.1093/eurheartj/ehn483. 
  • Boriani G, Diemberger I, Martignani C, Biffi M, Branzi A. The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems. Eur Heart J. 2006 Apr;27(8):893-4. 
  • Boriani G, Maron BJ, Shen WK, Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation. 2004 Oct 12;110(15):e438-42

[Ultimo aggiornamento: 18/06/2019 13:56:06]